Loading...

Wechat

Website

Table of Content

    25 August 2024, Volume 16 Issue 4 Previous Issue    Next Issue
    Chinese consensus experts on diagnosis and treatment of uterine carcinosarcoma (2024 edition)
    Gynecological Oncology Group, the Invasive and Noninvasive Medical Committee of Chinese Medical Doctor Association, Reproductive Tract Disease Diagnosis and Treatment Branch of the China Healthy Birth Science Association, Oncofertility Branch of the China Healthy Birth Science Association
    2024, 16 (4):  385-391.  doi: 10.3969/j.issn.1674-5671.2024.04.01
    Abstract ( 423 )   PDF   Save
    Related Articles | Metrics
    Current status of CAR-T therapy for multiple myeloma: Challenges and hopes coexist
    LI Yixue, LI Yajun, Zeng Ruolan, HE Yizi, WANG Caiqin, XIAO Ling, ZHOU Hui
    2024, 16 (4):  392-398.  doi: 10.3969/j.issn.1674-5671.2024.04.02
    Abstract ( 297 )   PDF   Save
    Related Articles | Metrics
    A novel immunotherapy strategy for relapsed/refractory multiple myeloma: GPRC5D bispecific antibody
    XIAO Wanting, ZHANG Chunyan, TIAN Biao, GAO Yaya, GAO Guangxun
    2024, 16 (4):  399-404.  doi: 10.3969/j.issn.1674-5671.2024.04.03
    Abstract ( 181 )   PDF   Save

    Related Articles | Metrics
    Effects of PPP2R5C on proliferation, apoptosis, and drug sensitivity of multiple myeloma cells
    LIANG Yuanzheng, WANG Henan, WANG Liang
    2024, 16 (4):  405-411.  doi: 10.3969/j.issn.1674-5671.2024.04.04
    Abstract ( 146 )   PDF   Save
    Objective To investigate the effects of protein phosphatase 2 regulatory subunit B'gamma (PPP2R5C) on the proliferation, apoptosis and drug sensitivity of multiple myeloma (MM) cells. Methods The qRT⁃PCR and Western blot were used to detect the expression of PPP2R5C in human multiple myeloma cell lines (MM1S and RPMI⁃8226 cell lines) and normal peripheral blood mononuclear cells(PBMC). The MM1S cells were transfected with PPP2R5C interfering siRNA (si⁃PPP2R5C group) and its negative control (si⁃CTRL group), and PPP2R5C overexpressing plasmid (OE⁃PPP2R5C group) and its negative control (OE⁃CTRL group), respectively. Cell proliferation was detected by CCK⁃8 method, and cell apoptosis was detected by flow cytometry. The cells in the si⁃PPP2R5C group and si⁃CTRL group were treated with different concentrations of Bortezomib (BTZ) for 24 h, cell viability was measured by CCK⁃8 method and half maximal inhibitory concentration (IC50) values were calculated. After 1 nmol/L BTZ intervention for 24 h, the expression levels of BCL⁃2 and BAX in the si⁃PPP2R5C and si⁃CTRL groups were detected by qRT⁃PCR and Western blot, and Caspase⁃3/7 activity was detected by Caspase 3/7 activity detection kit, and cell apoptosis was detected by flow cytometry. Results Compared with PBMC cells, PPP2R5C was highly expressed in MM1S and RPMI⁃8226 cells at both mRNA and protein levels (all P<0.001). Compared with the si⁃CTRL group, the cell proliferation activity of si⁃PPP2R5C group was inhibited after 48 h and 72 h of cell culture (all P<0.001), the apoptosis rate was significantly increased (5.97% vs 14.39%, P<0.001). Compared with the OE⁃CTRL group, the cell proliferation activity of OE⁃PPP2R5C group was enhanced at these time points after 48 h and 72 h of cell culture (all P<0.01). The IC50 value of BTZ in the si⁃PPP2R5C group was significantly lower than that in the si⁃CTRL group(3.40 nmol/L vs 10.37 nmol/L, P<0.001). Moreover, compared with the control group and si⁃CTRL+BTZ group, mRNA and protein level of BCL⁃2 in the si⁃PPP2R5C+BTZ group were decreased, while the mRNA and protein level of BAX, Caspase 3/7 activity and cell apoptosis rate were increased (all P<0.05).Conclusions PPP2R5C is highly expressed in MM cell lines. PPP2R5C knockdown can inhibit the cell proliferation and promote apoptosis of MM cells, and increase the drug sensitivity of BTZ.
    Related Articles | Metrics
     Single-center clinical experience of daratumumab combined with bendamustine in the treatment of multiple myeloma patients with secondary extramedullary disease
    ZHOU Da, WANG Mingyue, LI Zhe, HE Qing, CEN Hong
    2024, 16 (4):  412-416.  doi: 10.3969/j.issn.1674-5671.2024.04.05
    Abstract ( 129 )   PDF   Save
     Objective To investigate the efficacy and safety of daratumumab combined with bendamustine in patients with relapsed/refractory multiple myeloma complicated by secondary extramedullary disease. Methods The clinical data of  patients with relapsed/refractory multiple myeloma complicated by secondary extramedullary disease hospitalized in Guangxi Medical University Cancer Hospital from January 2021 to December 2023 were analyzed retrospectively. All patients had progressive disease on at least 3 prior treatment lines and followed by combination therapy with daratumumab and bendamustine. The efficacy and safety of the treatment were assessed based on the International Myeloma Working Group (IMWG) criteria and the National Cancer Institute⁃Common Terminology Criteria for Adverse Events (NCI⁃CTCAE) version 5.0. Results A total of 12 patients were included in the analysis, with 2 achieving complete response, 4 achieving partial response, 2 achieving minimal response, 1 achieving stable disease, and 3 experiencing  progressive disease. The overall response rate was 50%, and the median progression⁃free survival was 8 months. All patients experienced hematological toxicity, 4 of which were grade Ⅲ-Ⅳ. Additionally, 3 patients developed pneumonia during treatment, no treatment⁃related deaths occurred. Conclusions The combination of daratumumab and bendamustine demonstrates effectiveness in treating relapsed/refractory multiple myeloma complicated by secondary extramedullary disease, with manageable toxicities. This result deserves further investigation with a larger patient population.
    Related Articles | Metrics
    Effects of disulfiram combined with Cu2+ induced cuproptosis on proli-feration,migration and invasion of hepatoma Hep3B cells 
    TANG Min, HUANG Juanchan, WEI Xingwen, LUO Xuewen, ZHAO Wei
    2024, 16 (4):  417-423.  doi: 10.3969/j.issn.1674-5671.2024.04.06
    Abstract ( 285 )   PDF   Save
    Objective To investigate the effects of disulfiram (DSF) combined with Cu2+ on the proliferation, migration and invasion of hepatoma Hep3B cells and the underlying mechanism. Methods Hepatoma Hep3B cells were cultured in vitro. DSF (30 nmol/L) solution, Cu2+ (1 μmol/L) solution and copper chelating agent ammonium tetrathiomolybdate Ⅵ (ATTM) (30 nmol/L) solution were used individually or combinedly for intervention. The cells treated with dimethyl sulfoxide (DMSO) (30 nmol/L) were used as the control group. CCK⁃8, scratch test and Transwell cell test were used to detect the proliferation, migration and invasion ability of cells. The expression of copper death related proteins dihydrolipoamide S⁃acetyltransferase (DLAT) and ferredoxin 1 (FDX1) were detected by immunofluorescence assay.  Results Compared with the control group, the proliferation, migration and invasion ability of Hep3B cells were significantly decreased after DSF or Cu2+ or DSF+Cu2+ combined intervention (all P<0.05), and the decrease was more significant in DSF+Cu2+ combined intervention (all P<0.0001). After addition of DSF combined with Cu2+ to ATTM, the inhibitory effects of DSF combined with Cu2+ on the proliferation, migration and invasion of Hep3B cells were reversed, and the proliferation, migration and invasion ability cells were enhanced compared with DSF+Cu2+ group (all P<0.05). Compared with the control group, the fluorescence intensity of copper death related proteins DLAT and FDX1 showed no significant increase after DSF or Cu2+ intervention, but the fluorescence intensity of DLAT protein increased while that of FDX1 protein decreased after DSF+Cu2+ combined intervention, and the expression trend of DLAT and FDX1 proteins was reversed after the addition of ATTM. Conclusions DSF combined with Cu2+ can inhibit the proliferation, migration and invasion of Hep3B cells, probably through the induction of cuproptosis.
    References | Related Articles | Metrics
    Comparison of the separation and purification methods of small extracellular vesicles in mesenchymal stem cells
    LI Tingting, LIU Yan
    2024, 16 (4):  424-432.  doi: 10.3969/j.issn.1674-5671.2024.04.07
    Abstract ( 154 )   PDF   Save
    Objective To explore the optimal method for separating and purifying small extracellular vesicles from the supernatant of mesenchymal stem cells. Methods Three standard extracellular vesicle separation procedures, including differential (ultra) centrifugation (dUC), polyethylene glycol (PEG) precipitation and QIAGEN kit method, were compared; small extracellular vesicles were extracted through ultrafiltration concentration and filtration with a 0.22 μm or 0.45 μm filter membrane, respectively, based on the standard procedure. The quality of the extracted extracellular vesicles and the efficiency of the separation methods were analyzed by comparing the operation duration and simplicity of the separation methods, and evaluating the morphological structure, particle size distribution and marker protein expression of small extracellular vesicles through transmission electron microscopy, nanoparticle tracking analysis technology(NTA)  and  Western  blot, respectively. The CCK⁃8 assay and Transwell migration assay were used to evaluate the effects of small extracellular vesicles extracted by the modified methods on the proliferation and migration of breast cancer cells. Results Small extracellular vesicles could be isolated by all these three methods, and the QIAGEN kit method has the shortest operation duration, 48 min on average, and up to 93 min after ultrafiltration concentration (P<0.0001). The PEG precipitation method had the longest operation duration, 487 min on average, and up to 547 minutes with additional ultrafiltration concentration step (P<0.0001). The average operation duration of the dUC method was 217 minutes; after the addition of the ultrafiltration conentration step, it was up to 274 minutes (P<0.0001). The typical "saucer" structure was observed in all samples under transmission electron microscopy, and the particle sizes of each sample ranged between 30 and 200 nm except for that in the QIAGEN kit method, which was above 200 nm. Among them, the dUC+0.45 μm filter membrane group had the largest number and the most complete small exbracellular vesicles structures in one field of view. Western blot results showed that positive marker proteins CD9, CD63 and TSG101 were expressed in the samples extracted by different methods, but the negative marker calnexin was not expressed. However, after 0.22 μm filter membrane filtration, the bands of small extracellular vesicle marker proteins became shallow. The NTA results showed that the proportion of small extracellular vesicles filtered by dUC+0.45 μm filter membrane was the highest, reaching 94.86%. The particle size distribution maps of samples extracted by different methods showed that the NTA results of dUC standard and the dUC+0.45 μm filter membrane groups showed a unimodal and smooth curve. Samples filtered by dUC+0.45 μm filter membrane were selected for breast cancer cell phenotype experiment, and the results showed that cell proliferation and migration were enhanced (all P<0.05). Conclusions dUC is an effective method for separating small extracellular vesicles from mesenchymal stem cells. The quality of small extracellular vesicles can be improved by filtering the cell supernatant with 0.45 μm filter membrane before ultracentrifugation. 
    Related Articles | Metrics
    Gene expression profiling of peripheral blood B cells before and after surgery for hepatocellular carcinoma based on single-cell RNA sequencing technology
    LIANG Si, SHENG Yonghong, LIU Shun, LIU Meiliang, YANG Yu, LEI Lei, WU Lili, ZENG Xiaoyun
    2024, 16 (4):  433.  doi: 10.3969/j.issn.1674-5671.2024.04.08
    Abstract ( 171 )   PDF   Save
    Objective To investigate the changes of gene expression profiles of peripheral blood B cells in hepatocellular carcinoma (HCC) patients before and after surgery. Methods Peripheral blood samples of 3 HCC patients who underwent hepatectomy for treatment at the Guangxi Medical University Cancer Hospital in September 2022 were collected before and after surgery, peripheral blood monoculear cell (PBMC) were extracted and single⁃cell RNA sequencing (scRNA⁃seq) was performed. B cell number analysis, up⁃ and down⁃regulated gene difference analysis, KEGG analysis, GSEA⁃KEGG and GSEA⁃GO analysis, and cell communication analysis were performed based on the sequencing data to compare the dynamic changes of B cells before and after surgery. Results PBMC was analyzed by scRNA⁃seq to identify clusters of cells with marker genes MS4A1 and CD79A, namely, B⁃cell clusters. After regrouping analysis, the B⁃cell clusters were classified into three cell subpopulations, namely, memory B cells, naive B cells, and plasmablasts. Compared with pre⁃operative group, the percentage of naive B cells and plasmablasts increased, and the percentage of memory B cells decreased after operation. A total of 285 significantly differentially expressed genes (DEGs) were screened in B cells before and after surgery, of which 152 genes including S100A8, S100A9, IL1R2 and MALAT1 were significantly up⁃regulated after surgery (P<0.05), and 133 genes including RPS27A, RPS3A, RPS12 and RPS3 were significantly down⁃regulated after surgery(P<0.05). KEGG analysis revealed that significantly down⁃regulated DEGs in post⁃operative B cells were mainly enriched in ribosomal, antigen processing and presentation pathways. GSEA⁃KEGG analysis revealed that the gene set up⁃regulated in post⁃operative B cells was significantly enriched in transcriptional dysregulation and P53 signaling pathway in cancer, while the gene set down⁃regulated was significantly enriched in ribosomal, antigen processing and presentation pathways. GSEA⁃GO analysis revealed that the gene set up⁃regulated in post⁃operative B cells was significantly enriched in cyclooxygenase P450 pathway, signaling pattern recognition receptor activity, and the down⁃regulated gene set was significantly enriched in immunoglobulin complex and T⁃cell receptor complex. Communication between B cells and T cells was enhanced after surgery, and the communication probability of post⁃operative ligand and receptor pairs of CD22⁃PTPRC between B cells and B cells, and between B cells and Mono cells was up⁃regulated (P<0.01). Either before or after surgery, the CD22 signaling pathway had a strongly ability to regulate the communication between B cells and T cells. Conclusions The gene expression profile of peripheral blood B cells in HCC patients changes dynamically before and after surgery, and is correlated with the immune function of peripheral blood B cells. This result provides a new reference for the study of the anti⁃tumor immune function of peripheral blood B cells.
    Related Articles | Metrics
    Analysis of risk factors and attributable disease burden of four major chronic diseases including cancer in the Chinese population
    SU Xin, FAN Wenyi, XU Xinye, XU Xuedong
    2024, 16 (4):  442-447.  doi: 10.3969/j.issn.1674-5671.2024.04.09
    Abstract ( 304 )   PDF   Save
    Objective To explore the main risk factors for cancer, cardiovascular and cerebrovascular diseases, diabetes and chronic respiratory disease (referred to as the four major chronic diseases), and to evaluate the disease burden associated with the exposure to risk factors. Methods  The data of this study were collected from the 2019 Global Burden of Disease Study (GBD) database. By analyzing the number of deaths and disability⁃adjusted life years (DALYs) of four major chronic diseases among Chinese residents in 2019, the proportion of these four major chronic diseases attributable to the exposure to related risk factors was determined. Results The primary risk factor for disease burden was the tobacco exposure, which accounted for 31.4% of DALYs. High systolic blood pressure was the main risk factor for cardiovascular and cerebrovascular diseases, which accounted for 55.6% of DALYs. The common risk factors of four major chronic diseases were tobacco exposure, air pollution and high body mass index (BMI); among them, tobacco exposure had the highest proportion of attributable risk in the disease burden of cancer and chronic respiratory disease. Diet related risk factors, alcohol consumption, and physical inactivity were associated with cancer, cardiovascular and cerebrovascular diseases, and diabetes. The results of the attribution analysis of major cancers showed that lung cancer had the highest proportion of attributable risk due to tobacco exposure, followed by esophageal cancer, gastric cancer, liver cancer, and colorectal cancer. Conclusions Tobacco exposure, air pollution and high BMI are common risk factors for the four major chronic diseases in Chinese residents. This result provides important evidence for high⁃risk population screening.
    Related Articles | Metrics
    Analysis of screening results of early diagnosis and treatment program for colorectal cancer in rural areas Fengtai district,Beijing,2015—2022
    ZHANG Tianyang, XIAO Wen, XIN Zhenjiang, XIE Junqing
    2024, 16 (4):  447-453.  doi: 10.3969/j.issn.1674-5671.2024.04.10
    Abstract ( 92 )   PDF   Save
    Objective To analyze the screening results of early diagnosis and treatment program for colorectal cancer in rural areas of Fengtai district, Beijing from 2015 to 2022. Methods The permanent residents aged 40 to 74 years old in rural early cancer diagnosis and early treatment project sites in Fengtai district, Beijing from 2015 to 2022 were selected for screening. The high risk population of colorectal cancer were initially screened through questionnaire survey and fecal immunochemical test, and colorectal colonoscopy was performed. The high risk rate, colonoscopy compliance rate and detection rate of colorectal cancer were calculated. Results A total of 14,972 residents in Fengtai district participated in high risk assessment of colorectal cancer, of which 5,961 people were found to be at high risk of colorectal cancer, with a high risk rate of 39.81%. The high risk rate of males was lower than females (P<0.001), the highest was in the 70-74 age group (43.53%) and the lowest was in the 40-44 age group (31.88%). Colonoscopy was performed in 3,314 cases, with the compliance rate of 55.59%, the highest was in the 45-49 age group (63.23%) and the lowest was in the 65-69 age group (48.58%). Among the colonoscopy results, the detection rate of abnormal lesions was 5.07%, among which the detection rates of advanced adenoma, other lesions with moderate or severe dysplasia, early cancer, and advanced cancer were 4.77%, 0.09%, 0.15%, and 0.06%, respectively. The detection rates of advanced adenoma, early cancer, and advanced cancer in males are higher than those in females, while the detection rates of other lesions with moderate or severe dysplasia was lower than those in females. There was a statistically significant difference in the detection rate of advanced adenoma among different age groups (P<0.001), and the detection rate was highest in the 70-74 age group (9.57%). Conclusions The high risk rate of colorectal cancer screening in rural areas of Fengtai district, Beijing is relatively high, and females have a higher risk than males, and the elderly is the high risk population. In the future, it is necessary to strengthen the detection and screening of these high risk population, and improve their compliance. 
    Related Articles | Metrics
    Construction and validation of nomogram model for predicting the relatively long-term survival of metastatic breast cancer based on SEER database
    ZHANG Wenhai, LIAN Bin, HOU Qinhan, LIANG Xinguang, YANG Qiujiao, LIANG Ling, CHEN Binjie, WEI Changyuan
    2024, 16 (4):  454-461.  doi: 10.3969/j.issn.1674-5671.2024.04.11
    Abstract ( 127 )   PDF   Save
    Objective To construct and validate a nomogram model for predicting the relatively long⁃term survival in patients with metastatic breast cancer based on the SEER database. Methods The clinicopathological data of patients with metastatic breast cancer from 2010 to 2015 in SEER database were randomly divided into a training set and a validation set in a 7∶3 ratio. Univariable and multivariable logistic regression analyses were performed and the nomogram model was constructed in the training set. The receiver operating characteristic (ROC) curve, calibration curve, and clinical decision curve were plotted for both the training and validation sets to evaluate the efficacy of the model. Results A total of 6,515 eligible patients with metastatic breast cancer were included, with 4,560 patients in the training set and 1,955 patients in the validation set. In the training set, 2,229 (48.9%) patients were relatively long⁃term survivors (>24 months), and in the validation set, 970 (49.6%) patients were relatively long⁃term survivors. Multivariable Logistic regression analysis showed that age, marital status, race, histological grade, T stage, N stage, brain metastasis, liver metastasis, lung metastasis, time from initial diagnosis to treatment, estrogen receptor (ER) status, progesterone receptor (PR) status, surgical approach and molecular subtype were all independent factors which could affect the relatively long⁃term survival in patients with metastatic breast cancer (all P<0.05). The AUCs of the nomogram model in the training and validation sets were 0.738 (95%CI: 0.724-0.752) and 0.745 (95%CI: 0.723-0.766), respectively. The calibration curve showed a good consistency between the  predicted outcomes and actual outcomes of the model, and the clinical decision curve showed a high net benefit of the model. Conclusions The nomogram model constructed in this study can predict the relatively long⁃term survival of patients with metastatic breast cancer, providing an auxiliary decision⁃making basis for clinical practice and supporting individualized treatment decisions.
    Related Articles | Metrics
    Preoperative CT signs combined with clinical indicators predict the expression of cytokeratin 19 in hepatocellular carcinoma
    ZHANG Siyi, HUANG Xiangyang, QIN Yunying, LIU Lijuan, HUANG Caiyun, LUO Ningbin
    2024, 16 (4):  461-467.  doi: 10.3969/j.issn.1674-5671.2024.04.12
    Abstract ( 101 )   PDF   Save
    Objective To investigate the value of preoperative CT signs combined with clinical indicators in predicting the expression of cytokeratin 19 (CK19) in patients with hepatocellular carcinoma (HCC). Methods HCC patients admitted to Guangxi Medical University Cancer Hospital from January 2019 to December 2021 were enrolled as the studied objects. The clinical data and CT signs were collected and randomly divided into training group and validation group according to a ratio of 7: 3. The independent predictors of CK19 expression was analyzed by Logistic backward stepwise regression and a predictive model was constructed. The receiver operating characteristic (ROC) curve, calibration curve, and decision curve were used to evaluate the predictive efficacy of the model. Results A total of 380 HCC patients were enrolled, of which 68 (17.9%) were CK19 positive. Age, AFP, rim arterial phase hyperenhancement, delayed central enhancement, and intratumoral artery were independent predictors of CK19 expression in HCC (all P<0.05). The area under the curve (AUC) of CK19 expression predicted by the clinical imaging model in the training group and validation group was 0.789 and 0.748, respectively. The calibration curve showed a good fitting degree of the clinical imaging model. The decision curve showed that the clinical image model had good clinical application value. Conclusions Preoperative CT signs combined with age and AFP effectively predict CK19 expression in HCC patients.
    Related Articles | Metrics
    Investigation on the status quo of the quality of life in patients with intermediate and advanced liver cancer treated by immunotherapy
    LU Feichen, YOU Xuemei, ZHAO Fengjuan, LI Fanrong, WEI Shuangshuang, YANG Lijie
    2024, 16 (4):  468-473.  doi: 10.3969/j.issn.1674-5671.2024.04.13
    Abstract ( 125 )   PDF   Save
    Objective To analyze the status quo and influencing factors of the quality of life in patients with intermediate and advanced liver cancer treated by immunotherapy, and to provide evidence for improving quality of life in patients with intermediate and advanced liver cancer treated by immunotherapy. Methods A total of 211 patients with intermediate and advanced liver cancer who received immunotherapy in the Guangxi Medical University Cancer Hospital from January 2022 to July 2023 were selected as the study objects. A cross⁃sectional investigation was conducted with general data questionnaire, hospital anxiety and depression scale (HADS), functional assessment of cancer therapy⁃hepatobiliary questionnaire (FACT⁃Hep). Multiple linear regression was used to analyze the influencing factors of quality of life. Results The total score of quality of life in patients with intermediate and advanced liver cancer treated by immunotherapy was (130.04±15.28). Multiple linear regression analysis showed that HADS⁃D>7 score (β=-10.257, 95%CI:  -14.862, -5.653) and previous hepatectomy (β=-8.484, 95%CI: -12.765, -4.203) were the influencing factors of poor total quality of life. HADS⁃A>7 score (β=-2.273, 95%CI: -3.866, -0.681), previous hepatectomy (β=-2.500, 95%CI: -3.825, -1.174) were the influencing factors of the poor score of physical condition; and secondary school education level (β=2.574, 95%CI: 0.862, 4.286), TACE/HAIC (β=1.746, 95%CI: 0.010, 3.482) were the influencing factors of the better score of physical condition. Monthly family income was 4,000-5,999 yuan (β=-2.357, 95%CI: -4.429, -0.284), HADS⁃D>7 score (β=-1.182, 95%CI: -1.992, -0.372) were the influencing factor of poor score of social/family status. HADS⁃D>7 score (β=-3.422, 95%CI: -4.276, -2.568) was the influencing factor of the poor score of psychological status; and multiple tumors score (β=1.053, 95%CI: 0.131, 1.975) was the influencing factor of the better score of psychological status. HADS⁃D>7 score (β=-2.483, 95%CI: -3.526, -1.440) was the influencing factor of the poor score of functional status. Previous hepatectomy (β=-4.255, 95%CI: -6.560, -1.951) was the influencing factor of the poor score of hepatobiliary specific status dimension; and TACE/HAIC (β=3.555, 95%CI: 0.590, 6.520) was the influencing factor of the better score of hepatobiliary specific status dimension. Conclusions The overall health status of patients with intermediate and advanced liver cancer treated by immunotherapy is poor. It is necessary to pay attention to patients with low education level, low monthly family income, combined therapy, and heavy disease and psychological burden, and effective individualized programs should be formulated and implemented to improve the quality of life.
    Related Articles | Metrics
    Longitudinal association between symptom clusters and quality of life in perioperative rectal cancer patients: a network-based analysis
    WU Yan, JIANG Honghong, YANG Yongxiang, CHEN Jie
    2024, 16 (4):  474-480.  doi: 10.3969/j.issn.1674-5671.2024.04.14
    Abstract ( 172 )   PDF   Save
    Objective To construct a network⁃based model of symptom clusters and quality of life in perioperative rectal cancer patients, and to explore inter⁃symptoms and their association with quality of life, providing a theoretical basis for the development of targeted symptom management strategies. Methods A total of  255 patients with rectal cancer hospitalized in the department of gastrointestinal surgery of Special Medical Center of PLA Rocket Force from November 2021 to November 2023 were enrolled by the convenience sampling method. The general information questionnaire, M.D. Anderson symptom inventory (MDASI), European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ⁃C30) were used to investigate the socio⁃demographic and clinical data of rectal cancer patients as well as symptom severity and quality of life status at preoperatively(T1), 1 day postoperatively(T2), and 7 days postoperatively(T3), respectively. One⁃way ANOVA was used to assess the differences in symptoms and various domains of the quality of life in patients at each time point. The network models of symptom clusters and quality of life in the perioperative rectal cancer patients were constructed by a network⁃based analysis; core symptoms and node associations were identified by calculating node strength centrality and edge weight values. Results Except for the cognitive function domain of life quality (P=0.311), there were significant differences in patients' symptoms and life quality were statistically significant at T1, T2 and T3, respectively (all P<0.05). In the three network models, symptoms were negatively correlated with all the domains of life quality. At stage T1, the strongest correlation was between distress and social function (-0.22); at stage T2, the strongest correlation was between lack of appetite and physical function (-0.34); at stage T3, the strongest correlation was between difficulty remembering and cognitive function (-0.30). The perioperative symptom clusters of rectal cancer patients were mainly manifested as disease behavior symptoms (including shortness of breath, dry mouth, difficulty remembering, numbness), psychoneurotic symptoms (including sad, distress,drowsy, sleepy, pain, fatigue) and gastrointestinal symptoms (including lack of appetite, nausea, vomiting). According to the node strength values, shortness of breath (1.30), dry mouth (1.09), and difficulty remembering (1.03) were the core symptoms, and emotional function (1.16) was the core domain in stage T1; shortness of breath (1.42), sad (1.23), and distress (1.20) were the core symptoms, social function (1.24) was the core domain in stage T2; sad (1.45), lack of appetite (1.28 ), and drowsy (1.26) were core symptoms, while emotional function (1.25) was the core domain in stage T3. The three network models were highly stable, with network connection strength stability coefficients of 0.518, 0.561, and 0.672, respectively. Conclusions Patients with rectal cancer experience a stable cluster of disease symptoms during the perioperative period, which are strongly associated with the quality of life. It is necessary to pay attention to symptom clusters and adopt targeted management measures.
    Related Articles | Metrics
    Machine learning-based analysis of risk factors for postoperative facial paralysis in patients with parotid tumors
    LI Shuimei, XU Sujuan, YIN Hai, ZHONG Yanmei, LIU Yingying, LIANG Jingyan
    2024, 16 (4):  481-486.  doi: 10.3969/j.issn.1674-5671.2024.04.15
    Abstract ( 122 )   PDF   Save
    Objective To analyze the influencing factors of postoperative facial paralysis in patients with parotid tumors by using machine learning technique. Methods The data of patients with parotid tumors in the medical record system of Guigang People's Hospital from January 2013 to December 2023 were collected retrospectively. LASSO regression was used to screen the potential risk factors of postoperative facial paralysis, followed by an disordered multi⁃classification Logistic regression analysis to determine the risk factors of postoperative facial paralysis. Results 54 of 395 patients with parotid tumors experienced facial paralysis, including 40 cases of transient facial paralysis and 14 cases of permanent facial paralysis. Disordered multi⁃classification LASSO regression identified 26 risk factors of postoperative facial paralysis in patients with parotid tumors under the optimal lambda value, which were included in the disordered multi⁃classification Logistic regression analysis. The results showed that tumor location, tumor nature, preoperative mass tenderness, smoking, glutamyl transferase, chloride concentration, magnesium concentration, and partial thromboplastin time were the influencing factors for transient facial paralysis (all P<0.05); tumor nature tumor volume, age, and body mass index were influencing factors for permanent facial paralysis (all P<0.05). Conclusions The key influencing factors of postoperative facial paralysis in patients with parotid tumors are identified by using the machine learning technique, helping the early identification of high⁃risk groups for postoperative facial paralysis and providing a scientific basis for the prevention and prediction of facial paralysis.
    Related Articles | Metrics
    Effects of sarcopenia on prognosis of prostate cancer treatment: a Meta-analysis
    SU Lili, LAN Zhenyu, LIN Huizhe, YAN Fangna, CHEN Weilian, LIN Wei
    2024, 16 (4):  487-493.  doi: 10.3969/j.issn.1674-5671.2024.04.16
    Abstract ( 140 )   PDF   Save
    Objective To investigate the predictive effects of sarcopenia on the prognosis of prostate cancer after comprehensive treatment and its value. Methods Literature data on the association between prostate cancer and sarcopenia up to October 2023 were retrieved from Pubmed and Embase databases. Literature screening, data extraction and quality evaluation were conducted according to the inclusion and exclusion criteria. Stata 9.0 software (Stata Corporation, USA) was used for the Meta⁃analysis to evaluate the incidence of sarcopenia and its effect on the overall survival (OS) and progression⁃free survival (PFS) outcomes of prostate cancer. Results A total of 1,854 prostate cancer patients were included in 10 studies. Meta⁃analysis showed that the incidence of sarcopenia in prostate cancer was 60% (95%CI: 48%-72%). Subgroup analysis with different treatments modalities showed that the incidence of sarcopenia was 48% (95%CI: 28%-67%) in prostate cancer patients treated with chemotherapy/endocrine therapy and 77% (95%CI: 64%-89%) in the endocrine therapy group, and the incidence of sarcopenia in the other groups was 64% (95%CI: 45%-82%). Subgroup analysis of different types of prostate cancer showed that the incidence of sarcopenia was 64% (95%CI: 47%-80%) in the castration resistant prostate cancer group and 58% (95%CI: 0.37-0.79) in the metastatic prostate cancer group. Sarcopenia significantly shortened the OS (HR=1.53, 95%CI: 1.00-2.33) in patients with metastatic prostate cancer and PFS (HR=2.09, 95%CI: 1.21-3.61) in patients with chemotherapy/endocrine therapy for prostate cancer. Conclusions The incidence of sarcopenia is high in prostate cancer, and can shorten the prognosis after prostate cancer treatment, especially for metastatic prostate cancer and the patients receiving chemotherapy and endocrine therapy, though large⁃size samples are needed for verification.
    Related Articles | Metrics
    Research progress on the mechanism of Pirfenidone anti-tumor action
    DI Yingjie, XUE Yaoqin, REN Jinrui, OU Aixin, LIU Yue
    2024, 16 (4):  494-498.  doi: 10.3969/j.issn.1674-5671.2024.04.17
    Abstract ( 236 )   PDF   Save
    Related Articles | Metrics
    Research progress of Bevacizumab in the treatment of brain metastatic tumour
    HOU Qinhan, ZHANG Wenhai, WEI Changyuan
    2024, 16 (4):  499-504.  doi: 10.3969/j.issn.1674-5671.2024.04.18
    Abstract ( 198 )   PDF   Save
    Related Articles | Metrics